As of January 2025, Kaken Pharmaceutical has a market cap of $994.80M. This makes Kaken Pharmaceutical the world's 7783th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $835.75M | 4.47% |
2023 | $799.99M | -13.75% |
2022 | $927.56M | -7.60% |
2021 | $1.00B | 5.65% |
2020 | $950.21M | -34.02% |
2019 | $1.44B | 24.15% |
2018 | $1.16B | -16.41% |
2017 | $1.39B | -6.13% |
2016 | $1.48B | -25.39% |
2015 | $1.98B | 77.79% |
2014 | $1.11B | 47.91% |
2013 | $753.49M | 24.31% |
2012 | $606.13M | 24.24% |
2011 | $487.86M | 3.75% |
2010 | $470.22M | 24.81% |
2009 | $376.74M | -20.04% |
2008 | $471.17M | 26.02% |
2007 | $373.88M | -15.61% |
2006 | $443.03M | 1.09% |
2005 | $438.26M | 36.15% |
2004 | $321.90M | 25.46% |
2003 | $256.57M | 9.13% |
2002 | $235.11M | -30.95% |
2001 | $340.50M | - |